Statistics for A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Basedon Adeno-Associated Virus.

Total visits

views
A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Basedon Adeno-Associated Virus. 9

Total visits per month

views
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 2
March 2025 0
April 2025 0

File Visits

views
Vardas et al._A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant_2010.pdf 23